0.80Open0.80Pre Close22 Volume155 Open Interest79.00Strike Price3.00KTurnover1297.95%IV-0.66%PremiumDec 13, 2024Expiry Date1.81Intrinsic Value100Multiplier-1DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.8279Delta0.1369Gamma41.72Leverage Ratio-188.5538Theta0.0000Rho-34.54Eff Leverage0.0004Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet